Cerus Operating Margin from 2010 to 2024
| CERS Stock | USD 1.82 0.03 1.68% |
Check Cerus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cerus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 8.8 M or Selling General Administrative of 85.5 M, as well as many indicators such as Price To Sales Ratio of 2.37, Dividend Yield of 5.0E-4 or PTB Ratio of 13.75. Cerus financial statements analysis is a perfect complement when working with Cerus Valuation or Volatility modules.
Cerus | Operating Margin |
Latest Cerus' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Cerus over the last few years. It is Cerus' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cerus' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.02) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Cerus Operating Margin Regression Statistics
| Arithmetic Mean | (0.89) | |
| Coefficient Of Variation | (72.36) | |
| Mean Deviation | 0.51 | |
| Median | (0.71) | |
| Standard Deviation | 0.64 | |
| Sample Variance | 0.41 | |
| Range | 2.1122 | |
| R-Value | 0.58 | |
| Mean Square Error | 0.30 | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 0.08 | |
| Total Sum of Squares | 5.80 |
Cerus Operating Margin History
About Cerus Financial Statements
Cerus shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Cerus investors may analyze each financial statement separately, they are all interrelated. The changes in Cerus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cerus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cerus Corporation operates as a biomedical products company. The company was incorporated in 1991 and is headquartered in Concord, California. Cerus Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 631 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cerus Stock Analysis
When running Cerus' price analysis, check to measure Cerus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerus is operating at the current time. Most of Cerus' value examination focuses on studying past and present price action to predict the probability of Cerus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerus' price. Additionally, you may evaluate how the addition of Cerus to your portfolios can decrease your overall portfolio volatility.